Correlation of pre-CAR CD19 expression with responses and relapses after CAR T cell therapy.

2018
3051Background: Chimeric antigen receptor(CAR) T cells targeting CD19have shown excellent responses in patients with relapsed/refractory B-ALL. However, a subset of patients either do not respond...
    • Correction
    • Source
    • Cite
    • Save
    0
    References
    3
    Citations
    NaN
    KQI
    []
    Baidu
    map